Julien Daubriac

715 total citations
12 papers, 353 citations indexed

About

Julien Daubriac is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Julien Daubriac has authored 12 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Julien Daubriac's work include Occupational and environmental lung diseases (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Ubiquitin and proteasome pathways (2 papers). Julien Daubriac is often cited by papers focused on Occupational and environmental lung diseases (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Ubiquitin and proteasome pathways (2 papers). Julien Daubriac collaborates with scholars based in United States, France and Canada. Julien Daubriac's co-authors include Marie‐Claude Jaurand, Annie Renier, Françoise Galateau-Sallé, Françoise Le Pimpec‐Barthes, Didier Jean, Lance L. Munn, Jonathan W. Song, Janet M. Tse, Despina Bazou and Leslie I. Gold and has published in prestigious journals such as The FASEB Journal, Endocrinology and Cell Death and Differentiation.

In The Last Decade

Julien Daubriac

12 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julien Daubriac United States 10 123 96 77 77 56 12 353
Nathan R. Miselis United States 7 94 0.8× 246 2.6× 55 0.7× 73 0.9× 140 2.5× 10 465
Wei‐Wen Liu Taiwan 12 45 0.4× 194 2.0× 132 1.7× 26 0.3× 49 0.9× 51 515
Sara Galavotti United Kingdom 5 83 0.7× 273 2.8× 25 0.3× 32 0.4× 65 1.2× 11 501
Emma Åhrman Sweden 13 146 1.2× 202 2.1× 37 0.5× 39 0.5× 42 0.8× 20 516
Laura Mitrofan France 8 84 0.7× 161 1.7× 64 0.8× 17 0.2× 113 2.0× 11 390
María I. Calvo-Sánchez Spain 10 91 0.7× 145 1.5× 57 0.7× 23 0.3× 38 0.7× 15 420
Quanwei Shi China 11 37 0.3× 177 1.8× 170 2.2× 33 0.4× 86 1.5× 15 430
Annikka Linnala‐Kankkunen Finland 12 74 0.6× 284 3.0× 32 0.4× 23 0.3× 35 0.6× 22 528
Wei-Lun Sun Taiwan 7 64 0.5× 156 1.6× 63 0.8× 12 0.2× 84 1.5× 20 366
Chenjun Bai China 13 67 0.5× 399 4.2× 100 1.3× 26 0.3× 91 1.6× 26 564

Countries citing papers authored by Julien Daubriac

Since Specialization
Citations

This map shows the geographic impact of Julien Daubriac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julien Daubriac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julien Daubriac more than expected).

Fields of papers citing papers by Julien Daubriac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julien Daubriac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julien Daubriac. The network helps show where Julien Daubriac may publish in the future.

Co-authorship network of co-authors of Julien Daubriac

This figure shows the co-authorship network connecting the top 25 collaborators of Julien Daubriac. A scholar is included among the top collaborators of Julien Daubriac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julien Daubriac. Julien Daubriac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Wappett, Mark, Julien Daubriac, Ian Lobb, et al.. (2024). USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGF. Clinical and Translational Medicine. 14(4). e1648–e1648. 9 indexed citations
2.
Pandya, Unnati M., Ana Tellechea, Chinaza Egbuta, et al.. (2020). Calreticulin exploits TGF‐β for extracellular matrix induction engineering a tissue regenerative process. The FASEB Journal. 34(12). 15849–15874. 15 indexed citations
3.
Daubriac, Julien, Unnati M. Pandya, Kuang‐Tzu Huang, et al.. (2017). Hormonal and Growth Regulation of Epithelial and Stromal Cells From the Normal and Malignant Endometrium by Pigment Epithelium-Derived Factor. Endocrinology. 158(9). 2754–2773. 13 indexed citations
4.
Daubriac, Julien, Shiwei Han, Jelena Grahovac, et al.. (2017). The crosstalk between breast carcinoma-associated fibroblasts and cancer cells promotes RhoA-dependent invasion via IGF-1 and PAI-1. Oncotarget. 9(12). 10375–10387. 33 indexed citations
5.
Lecanda, Jon, Julien Daubriac, Unnati M. Pandya, et al.. (2016). TGF-β activates APC through Cdh1 binding for Cks1 and Skp2 proteasomal destruction stabilizing p27kip1 for normal endometrial growth. Cell Cycle. 15(7). 931–947. 11 indexed citations
6.
Čiplys, Evaldas, Leslie I. Gold, Julien Daubriac, et al.. (2015). High-level secretion of native recombinant human calreticulin in yeast. Microbial Cell Factories. 14(1). 165–165. 23 indexed citations
7.
Jean, Didier, Julien Daubriac, Françoise Le Pimpec‐Barthes, Françoise Galateau-Sallé, & Marie‐Claude Jaurand. (2012). Molecular Changes in Mesothelioma With an Impact on Prognosis and Treatment. Archives of Pathology & Laboratory Medicine. 136(3). 277–293. 73 indexed citations
8.
Song, Jonathan W., Julien Daubriac, Janet M. Tse, Despina Bazou, & Lance L. Munn. (2012). RhoA mediates flow-induced endothelial sprouting in a 3-D tissue analogue of angiogenesis. Lab on a Chip. 12(23). 5000–5000. 38 indexed citations
9.
Jaurand, Marie‐Claude, Annie Renier, & Julien Daubriac. (2009). Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk?. Particle and Fibre Toxicology. 6(1). 16–16. 106 indexed citations
10.
Daubriac, Julien, Jocelyne Fleury‐Feith, Laurence Kheuang, et al.. (2009). Malignant pleural mesothelioma cells resist anoikis as quiescent pluricellular aggregates. Cell Death and Differentiation. 16(8). 1146–1155. 24 indexed citations
11.
Andujar, Pascal, Céline Boulangé-Lecomte, Annie Renier, et al.. (2007). Clinico-pathological features and somatic gene alterations in refractory ceramic fibre-induced murine mesothelioma reveal mineral fibre-induced mesothelioma identities. Carcinogenesis. 28(7). 1599–1605. 7 indexed citations
12.
Daubriac, Julien, et al.. (2006). 98 Anoikis resistance in malignant pleural mesothelioma cells. Lung Cancer. 54. S24–S24. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026